Disease | li-fraumeni syndrome |
Comorbidity | C0014859|esophageal cancer |
Sentences | 1 |
PubMedID- 25135238 | The biomarker tp53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. |
Page: 1